UNFPA, US pharma firm partner to roll out HPV vaccination in Vietnam
The United Nations Population Fund (UNFPA) and the US-based pharmaceutical company Merc Sharp & Dohme (MSD) will join hands to support the Ministry of Health to roll out the human papillomavirus (HPV) vaccination programme in Vietnam from 2019 – 2021.
The United Nations Population Fund (UNFPA) and the US-based pharmaceutical company Merc Sharp & Dohme (MSD) will join hands to support the roll-out of the HPV vaccination programme in Vietnam from 2019 – 2021. (Photo: UNFPA)
Hanoi (VNA) – TheUnited Nations Population Fund (UNFPA) and the US-based pharmaceutical companyMerc Sharp & Dohme (MSD) will join hands to support the Ministry of Health to roll out the human papillomavirus (HPV) vaccination programme in Vietnam from 2019 – 2021.
An agreement to this effect was signed between the two sides in Hanoi on July 24.
Addressing the signingceremony, Deputy Director of the General Department of Preventive MedicineNguyen Minh Hang said vaccination is an effective and popular measure to prevent infectious diseases. Thanks to vaccines andthe national expanded immunization programme, many dangerous epidemics areeliminated or controlled, she noted.
“Evidence from international studies also confirms that a strategiccombination of sufficient coverage of HPV vaccination for adolescent girls andsufficient coverage of cervical screening and appropriate treatment for allwomen can eliminate cervical cancer as a public health problem within ourlifetime,” said Astrid Bant, UNFPA Representative in Vietnam.
MSD Vietnam ChiefRepresentative Koen Carel Kruijtbosch said developing vaccines that helpprotect public health is more than a business decision, it is a sharedmission. Every day in Vietnam, seven women die fromcervical cancer. This partnership between the UNFPA and the MSD hopes to address this disease burden, he added.
With a total budget of400,000 USD, the collaboration aims to conductevidence-based advocacy to encourage national and sub-national stakeholders toreduce the burden of HPV-related diseases and facilitate the gradualscale up of an HPV vaccination programme and the development of policies toprevent cervical cancer.
Cervical cancer remains amajor killer of women. Caused by HPV,cervical cancer claims the lives of more than 300,000 women every year, ofwhich 85 percent live in developing countries, according to the World HealthOrganisation. –VNA
Prime Minister Nguyen Xuan Phuc recently approved a project on enhancing equality in sexual and reproductive health, family planning and medical response in Vietnam.
Vietnam’s national cancer control strategy needed to address the serious problem of infectious agents, which cause more than 20 percent of malignancies in the world, said Prof Nguyen Chan Hung, Chairman of the Vietnam Cancer Society.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
The United Nations Population Fund (UNFPA) and the US-based pharmaceutical company Merc Sharp & Dohme (MSD) will join hands to support the roll-out of the HPV vaccination programme in Vietnam from 2019 – 2021. (Photo: UNFPA)
